1 / 62

Facts and Figures 2010

Facts and Figures 2010. Medicines and Health Care. The Association of the Pharmaceutical Industry in Norway (LMI). 1.01 The number of marketing authorisations, active ingredients and medicines in Norway. 1.02 New and withdrawn active ingredients.

abram
Télécharger la présentation

Facts and Figures 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Facts and Figures 2010 Medicines and Health Care The Association of the Pharmaceutical Industry in Norway (LMI)

  2. 1.01 The number of marketing authorisations, active ingredients and medicines in Norway

  3. 1.02 New and withdrawn active ingredients

  4. 1.03 Pharmaceutical sales in Norway in the last few years

  5. 1.04 Sales growth by value

  6. 1.05 Sales growth by volume (DDD)

  7. 1.06 The Norwegian pharmaceutical market by main therapeutic groups (ATC)

  8. 1.07 The top 25 pharmaceutical companies on the Norwegian market

  9. 1.08 The top 25 medicines on the Norwegian market in terms of sales value

  10. 1.09 The top 25 active ingredients as measured by defined daily doses (DDD)

  11. 1.10 Market share of generics (DDD)

  12. 1.11 Generics´ share of the generics interchangeable market

  13. 1.12 Market share of parallel imported medicines

  14. 1.13 Market share for wholesalers

  15. 1.14 Pharmacy chain market share

  16. 1.15 Pharmacy chain market share, excl. hospital pharmacies

  17. 1.16 Total number of users of prescription medicines in Norway

  18. 1.17 Number of inhabitants per pharmacy in Europe

  19. 1.18 Pharmaceutical consumption (DDD) in the Nordic countries

  20. 1.19 Distribution of the Nordic medicine market 2009

  21. 1.20 Nordic sales growth 2009

  22. 1.21 Medicine sales per inhabitant in the Nordic countries 2009

  23. 1.22 Leading pharmaceuticals on the global market

  24. 1.23 The Norwegian medicines market in relation to Europe

  25. 1.24 Leading pharmaceutical companies onthe global market

  26. 2.01 Changes in prices of medicines and general inflation

  27. 2.02 Public spending on reimbursable prescription medicines

  28. 2.03 Payment for pharmaceutical consumption

  29. 2.04 Public health expenditure per inhabitant

  30. 2.05 Public spending on health care and medicines

  31. 2.06 Expenditure on medicines in the private and public sector

  32. 2.07 Daily costs for the 25 most commonly used medicines

  33. 2.08 The consumer’s medicine expenses compared to other expenses

  34. 2.09 National Insurance expenditure

  35. 2.10 Health Care expenditure

  36. 2.11 International price index for medicines

  37. 2.12 VAT on medicines and other goods and services in Europe

  38. 2.13 Copayment for reimbursable medicines

  39. 2.14 Medicine costs as share of expenditure on health care in the OECD

  40. 2.15 Distribution of operating costs in specialized health care

  41. 3.01 Sales of non-prescription medicines

  42. 3.02 Non-prescription medicines, share of total market value (PRP) and DDD

  43. 3.03 The top 25 non-prescription medicines in terms of sales value

  44. 3.04 Non-prescription medicines sales by selected therapy groups (ATC)

  45. 3.05 The top 10 pharmaceutical companies in the non-prescription medicines market

  46. 3.06 Non-prescription medicines, market share in selected countries

  47. 3.07 Split by category of general sales outlets for non-prescription medicines except pharmacies

  48. 3.08 Segmentation of sales for non-prescription medicines

  49. 4.01 The top 10 veterinary medicines for aquaculture in terms of sales value

  50. 4.02 The top 10 veterinary medicines for mammals in terms of sales value

More Related